AF
EDIT icon

Allworth Financial’s Editas Medicine EDIT Stock Holding History

Allworth Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5K Buy
4,180
+692
+20% +$2.02K ﹤0.01% 3504
2026
Q1 		$8.62K Buy
3,488
+1,107
+46% +$2.34K ﹤0.01% 3614
2025
Q4 		$4.88K Sell
2,381
-100
-4% -$289 ﹤0.01% 3729
2025
Q3 		$8.61K Buy
2,481
+158
+7% +$441 ﹤0.01% 3233
2025
Q2 		$5.11K Buy
2,323
+1,947
+518% +$3.19K ﹤0.01% 3245
2025
Q1 		$605 Buy
376
+53
+16% +$78 ﹤0.01% 3630
2024
Q4 		$433 Sell
323
-508
-61% -$1.29K ﹤0.01% 3643
2024
Q3 		$2.83K Buy
831
+408
+96% +$1.78K ﹤0.01% 2814
2024
Q2 		$2.12K Sell
423
-228
-35% -$1.29K ﹤0.01% 2897
2024
Q1 		$4.83K Buy
651
+228
+54% +$1.89K ﹤0.01% 2423
2023
Q4 		$4.29K Sell
423
-38
-8% -$334 ﹤0.01% 2334
2023
Q3 		$3.6K Buy
461
+38
+9% +$326 ﹤0.01% 2271
2023
Q2 		$3.48K Buy
423
+23
+6% +$200 ﹤0.01% 2258
2023
Q1 		$2.9K Buy
400
+100
+33% +$889 ﹤0.01% 2252
2022
Q4 		$2.66K Buy
300
+164
+121% +$1.8K ﹤0.01% 2133
2022
Q3 		$2K Sell
136
-214
-61% -$3.33K ﹤0.01% 2135
2022
Q2 		$4K Buy
+350
New +$4.69K ﹤0.01% 1801
2022
Q1 		– Sell
-100
Closed -$3K – 2181
2021
Q4 		$3K Sell
100
-400
-80% -$13.8K ﹤0.01% 1637
2021
Q3 		$21K Buy
500
+100
+25% +$5.48K ﹤0.01% 1002
2021
Q2 		$23K Sell
400
-300
-43% -$11.1K ﹤0.01% 808
2021
Q1 		$29K Buy
700
+100
+17% +$5.7K ﹤0.01% 690
2020
Q4 		$42K Hold
600
– – ﹤0.01% 510
2020
Q3 		$17K Buy
+600
New +$19.5K ﹤0.01% 598

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Allworth Financial's EDIT Position: Q2 2026 in Review

Allworth Financial increased its Editas Medicine (EDIT) stake by 20% in Q2 2026, buying an estimated $2.02K and bringing the position to 4,180 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

Allworth Financial first reported a position in EDIT in Q3 2020 and has held it in 23 quarters since. The position peaked at $42K in Q4 2020. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Allworth Financial held 4,180 shares of Editas Medicine worth $13.5K as of Q2 2026.
  • Allworth Financial bought 692 Editas Medicine shares in Q2 2026, an estimated $2.02K.
  • Editas Medicine made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3504 holding.
  • Allworth Financial first reported a position in Editas Medicine in Q3 2020 and has held it in 23 quarters since.
  • Allworth Financial's Editas Medicine position peaked at $42K in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.